Concepedia

Controlled Dissolution Formulations

Controlled Dissolution Formulations is a pharmaceutical formulation strategy that belongs to the class of drug delivery systems in which the rate of drug release is governed by the controlled dissolution of the active agent, distinguished by its reliance on modulating solubility, particle size, matrix composition, or coating properties to achieve a predetermined and sustained release profile over time.

71

Publications

2.9K

Citations

298

Authors

111

Institutions

Publications per year

2017–2026

9

Parents

Publications

71

Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: Amorphous naproxen–cimetidine mixtures prepared by mechanical activation

Morten Allesø, Norman Chieng, Sönke Rehder et al. · Journal of Controlled Release · 2009 · 270 citations

, , +17

Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: A comparison with conventional tablets

Anders Sandberg, I. Blomqvist, U. E. Jonsson et al. · European Journal of Clinical Pharmacology · 1988 · 127 citations

, , +16

Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices

Yousef Javadzadeh, Leila Musaalrezaei, Ali Nokhodchi · International Journal of Pharmaceutics · 2008 · 122 citations · Full text

, , +17

Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates

Jayanti Nerurkar, H.W. Jun, James C. Price et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2005 · 122 citations

, , +17

Improvement of Dissolution Rates of Poorly Water Soluble APIs Using Novel Spray Freezing into Liquid Technology

Jiahui Hu, True L. Rogers, Judith Brown et al. · Pharmaceutical Research · 2002 · 122 citations

, , +17

1–5 of 71

Authors

298

  1. PK
    Piotr Kulinowski

    Jagiellonian University, Poland

    2 publications · 33 citations

    2

    h-index

  2. PD
    Przemysław Dorożyński

    Jagiellonian University, Poland

    2 publications · 33 citations

    2

    h-index

  3. KM
    Kenneth M. Feld

    Temple University, United States

    2 publications · 26 citations

    2

    h-index

  4. SM
    Sathyanarayana M. Upadrashta

    University of Missouri–Kansas City, United States

    2 publications · 125 citations

    2

    h-index

  5. JB
    Joseph B. Schwartz

    University of the Sciences, United States

    2 publications · 61 citations

    2

    h-index

1–5 of 298

Institutions

111

  1. Pfizer (United States)

    New York, United States

    3 h-index

    11 publications

    417 citations

  2. University of Missouri–Kansas City

    Kansas City, United States

    3 h-index

    7 publications

    403 citations

  3. Uniwersytet Komisji Edukacji Narodowej w Krakowie

    Krakow, Poland

    2 h-index

    2 publications

    33 citations

  4. Shenyang Pharmaceutical University

    Shenyang, China

    2 h-index

    10 publications

    452 citations

  5. Institute of Nuclear Physics, Polish Academy of Sciences

    Krakow, Poland

    2 h-index

    3 publications

    55 citations

  6. Bristol-Myers Squibb (United States)

    New York, United States

    2 h-index

    2 publications

    125 citations

  7. Jagiellonian University

    Krakow, Poland

    2 h-index

    6 publications

    99 citations

  8. University of the Sciences

    Philadelphia, United States

    2 h-index

    4 publications

    137 citations

1–8 of 111

Venues

  1. International Journal of Pharmaceutics

    16 publications · 591 citations

    14

    h-index

  2. Drug Development and Industrial Pharmacy

    10 publications · 288 citations

    10

    h-index

  3. Journal of Controlled Release

    5 publications · 418 citations

    5

    h-index

  4. AAPS PharmSciTech

    4 publications · 141 citations

    4

    h-index

  5. Journal of Pharmaceutical Sciences

    4 publications · 142 citations

    4

    h-index

1–5